Therapeutic cancer vaccine shows promise against multiple tumor types
Marc Baum went through all the usual steps to treat his bladder cancer—a couple of surgeries, radiation therapy and chemotherapy,
Read moreMarc Baum went through all the usual steps to treat his bladder cancer—a couple of surgeries, radiation therapy and chemotherapy,
Read moreThe COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the
Read moreA research team from the Institut national de la recherche scientifique (INRS) has improved the protective effect of a molecule
Read moreNagoya University researchers and colleagues have revealed that colorectal cancer tissues contain at least two types of fibroblasts (a type
Read moreRenal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new
Read moreScientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism
Read moreAccording to the results of research led by the Complutense University of Madrid (UCM), one the various strategies deployed by
Read moreResearchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases,
Read moreA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant
Read more